Proto Labs, Inc. $PRLB Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System lessened its holdings in shares of Proto Labs, Inc. (NYSE:PRLB) by 50.9% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,536 shares of the industrial products company’s stock after selling 11,952 shares during the quarter. New York State Teachers Retirement System’s holdings in Proto Labs were worth $658,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in PRLB. Group One Trading LLC purchased a new stake in Proto Labs during the 4th quarter worth approximately $25,000. NewEdge Advisors LLC lifted its holdings in Proto Labs by 7,380.0% during the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after buying an additional 738 shares in the last quarter. NBC Securities Inc. purchased a new position in Proto Labs in the 4th quarter valued at approximately $46,000. Modus Advisors LLC purchased a new position in Proto Labs in the 4th quarter valued at approximately $57,000. Finally, Aquatic Capital Management LLC acquired a new position in shares of Proto Labs in the third quarter worth $64,000. Hedge funds and other institutional investors own 84.54% of the company’s stock.

Proto Labs Trading Up 0.3%

Shares of PRLB opened at $74.60 on Tuesday. The firm has a market capitalization of $1.77 billion, a price-to-earnings ratio of 70.37 and a beta of 1.38. The firm’s fifty day simple moving average is $75.17 and its 200-day simple moving average is $64.39. Proto Labs, Inc. has a twelve month low of $38.48 and a twelve month high of $83.15.

Proto Labs (NYSE:PRLB) last issued its earnings results on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. The firm had revenue of $139.34 million during the quarter, compared to the consensus estimate of $135.31 million. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The company’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 earnings per share. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. On average, analysts predict that Proto Labs, Inc. will post 1.37 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the sale, the director owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. This trade represents a 5.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael R. Kenison sold 16,030 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total value of $1,113,924.70. Following the sale, the insider owned 18,683 shares of the company’s stock, valued at approximately $1,298,281.67. The trade was a 46.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 25,663 shares of company stock valued at $1,804,727. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

PRLB has been the topic of several analyst reports. Benchmark increased their price objective on Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Zacks Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 3rd. Wall Street Zen raised Proto Labs from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Weiss Ratings downgraded Proto Labs from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, June 29th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $65.33.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.